Floatz logo

Allocetra-Ots

Urinary Tract Infections

Enlivex Therapeutics Ltd.Phase 2Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Urinary Tract Infections cohort.

Asset / SponsorPhaseRating
NORMAL HUMAN SERUM ALBUMIN
EASL - CLIF Consortium
Phase 4BB
Cranberry
Rennes University Hospital
Phase 3B
Cotrimoxazole
Indonesia University
Phase 2CC
Gentamycin
Medstar Health Research Institute
Early Phase 1C
Lactobacillus Rhamnosus Gg
Medstar Health Research Institute
Early Phase 1C

View all 9 →

Same molecule, other indications

Allocetra-Ots is also rated in:

acute cholecystitisDormant
CCC
Indicative ·
55 / 100
View asset →
infectious disease with sepsisDormant
CCC
Indicative ·
55 / 100
View asset →
pneumoniaDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →